131 related articles for article (PubMed ID: 7050462)
1. [Combined use of heparin and urokinase in the patients with nephritis resistant to the conventional treatment and the significance of alpha 2-plasmin inhibitor in the therapy (author's transl)].
Koitabashi Y; Maruyama T; Ikoma M; Miyaji Y; Yamada K; Shimizu K
Rinsho Ketsueki; 1982 Mar; 23(3):309-18. PubMed ID: 7050462
[No Abstract] [Full Text] [Related]
2. [Changes in coagulation and fibrinolytic factors observed during heparin-urokinase-pulse combined therapy for nephritis resistant to conventional treatment in children].
Koitabashi Y; Ikoma M; Shibawaka T; Yamaguchi Y; Mio H; Doi K; Meguro T; Yamada K
Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1155-61. PubMed ID: 7505345
[TBL] [Abstract][Full Text] [Related]
3. Modifications in coagulation parameters induced by treatment associating urokinase (2000 u CTA/kg/h) with heparin.
Juhan I; Calas MF; Buonocore M; Mathieu P; Isnard G; Cazenave B; Serradimigni A
Thromb Haemost; 1979 Oct; 42(3):945-54. PubMed ID: 315625
[No Abstract] [Full Text] [Related]
4. [Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
Takasaki H; Shibata M
Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1271-80. PubMed ID: 7035725
[No Abstract] [Full Text] [Related]
5. [A case of arterial thrombosis successfully treated with a large dosage of urokinase--study on urokinase administration with special reference to alpha2-plasmin inhibitor (author's transl)].
Hayashi S; Yamada K
Rinsho Ketsueki; 1979 Apr; 20(4):400-9. PubMed ID: 156270
[No Abstract] [Full Text] [Related]
6. [Clinical significance of measuring alpha2-plasmin inhibitor levels in kidney diseases].
Koitabashi Y; Maruyama T; Ikoma M; Miyaji Y; Yamada K; Mizuhara H; Kawai S; Kuratsuji T; Shimizu K
Nihon Jinzo Gakkai Shi; 1983 Aug; 25(8):1035-43. PubMed ID: 6668744
[No Abstract] [Full Text] [Related]
7. Role of alpha 2-plasmin inhibitor in the appearance of fibrinolytic activity during urokinase administration, and an evaluation of the optimal urokinase dosage.
Hayashi S; Yamada K
Thromb Res; 1979; 16(3-4):393-400. PubMed ID: 92817
[No Abstract] [Full Text] [Related]
8. alpha 2-plasmin inhibitor levels in relation to modes of urokinase administration.
Matsuo O; Kosugi T; Mihara H; Ohki Y; Matsuo T
Thromb Res; 1980 Jul 1-15; 19(1-2):271-5. PubMed ID: 6449754
[No Abstract] [Full Text] [Related]
9. [State of the thrombin-plasmin system in nephrotoxic nephritis treated with heparin, urokinase, and uroplasmin].
Monastyrskiĭ VA; Ambarova LI
Arkh Patol; 1980; 42(1):17-22. PubMed ID: 6445726
[TBL] [Abstract][Full Text] [Related]
10. [Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
Sakuragawa N
Nihon Naika Gakkai Zasshi; 1979 May; 68(5):486-9. PubMed ID: 469353
[No Abstract] [Full Text] [Related]
11. [In vitro study of a human plasmin (CY 218) and its association with urokinase (author's transl)].
Brochier M; Griguer P
Rev Med Brux; 1981 Mar; 2(3):167-74. PubMed ID: 6453415
[No Abstract] [Full Text] [Related]
12. Heparin-urokinase treatment in aseptic dural sinus thrombosis.
Di Rocco C; Iannelli A; Leone G; Moschini M; Valori VM
Arch Neurol; 1981 Jul; 38(7):431-5. PubMed ID: 7018470
[TBL] [Abstract][Full Text] [Related]
13. [Experimental studies on the mode and amount of urokinase administration in thrombolytic therapy (author's transl)].
Matsuo O; Mihara H
Rinsho Ketsueki; 1977 Sep; 18(9):1097-101. PubMed ID: 592505
[No Abstract] [Full Text] [Related]
14. [Heparin therapy in various types of nephritis (author's transl)].
Akagi K; Enomoto T; Mizutani O; Kobayashi N
Nihon Jinzo Gakkai Shi; 1977 Nov; 19(11):849-69. PubMed ID: 609145
[No Abstract] [Full Text] [Related]
15. Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products.
Hasegawa H; Nagata H; Yamauchi M; Murakoshi T; Oguma Y; Takei H; Seya T; Murao M
Jpn Heart J; 1982 May; 23(3):339-47. PubMed ID: 6178853
[TBL] [Abstract][Full Text] [Related]
16. [Membranoproliferative glomerulonephritis and allied glomerulonephritis: development, treatment and prognosis (author's transl)].
Dohi K; Nakamoto Y; Kida H; Abe T; Fujioka M; Hattori N
Nihon Jinzo Gakkai Shi; 1981 Feb; 23(2):195-207. PubMed ID: 6166777
[No Abstract] [Full Text] [Related]
17. [Studies on blood coagulation and fibrinolytic activities in the three cases of cerebral infarction treated with urokinase. 1st report--120,000 I.U. administrated-- (author's transl)].
Fujita S; Itoga T; Shou T; Yamamoto H; Ishikawa H
Rinsho Ketsueki; 1978 Jun; 19(6):850-8. PubMed ID: 713046
[No Abstract] [Full Text] [Related]
18. [A case of microangiopathic hemolytic anemia associated with pre-eclampsia (author's transl)].
Ida T; Osaka Y; Tomura S; Ideura T; Abe T; Takeuchi J
Rinsho Ketsueki; 1980 Aug; 21(8):1178-84. PubMed ID: 7441884
[No Abstract] [Full Text] [Related]
19. [Curative effects of low-dose heparin combined with urokinase on primary nephritic syndrome complicated by severe hypercoagulabale state in children].
Fu Q; Zhou YL; Song XX; Wan SH; Mao LP; Hu JJ; Yu KG; Feng QH
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):921-2. PubMed ID: 22099206
[No Abstract] [Full Text] [Related]
20. Elevated urinary plasmin activity resistant to alpha2-antiplasmin in acute poststreptococcal glomerulonephritis.
Oda T; Tamura K; Yoshizawa N; Sugisaki T; Matsumoto K; Hattori M; Sawai T; Namikoshi T; Yamada M; Kikuchi Y; Suzuki S; Miura S
Nephrol Dial Transplant; 2008 Jul; 23(7):2254-9. PubMed ID: 18223261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
